Investing Profile

Ed Hurwitz

InvestorVC
Managing Director at MPM Capital
Photo of Ed Hurwitz, Managing Director at MPM Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
MPM Capital Managing Director
$100K - $5.0M
$1.5M
16
$100M
CompanyStageDateRound SizeTotal Raised
ReCode Therapeutics
Series BOct 2021$80M
Series AMar 2020$80M
$210M
Co-investors: Peter Thompson (OrbiMed), Rana Al-Hallaq (Pfizer Venture Investments), Kouki Harasaki (Bioluminescence Ventures), Helen Kim (Vida Ventures)
Protego Biopharma
Series AOct 2021$51M
$51M
Co-investors: Helen Kim (Vida Ventures)
BioIntervene
Series AJan 2020$30M
$30M
Larimar Therapeutics
Series EDec 2013$45M
Series DDec 2012$21M
$130M
Co-investors: Bruce Booth (Atlas Venture), Peter Barrett (Atlas Venture)
AGTC
Series BNov 2012$38M
$38M
Co-investors: Bill Harrington (Osage University Partners), Jill carroll (SR One)
Foldrx Pharmaceuticals
Series UnknownJun 2010$29M
Series BMay 2006$43M
$72M
Co-investors: Wei Li (Creacion Ventures), Heath Lukatch (Red Tree Venture Capital)
Avid Radiopharmaceuticals
Series DMay 2009$35M
$44M
Co-investors: Matthew Rhodes-Kropf (Tectonic Ventures)
Sunesis Pharmaceuticals
Post Ipo EquityApr 2009$44M
$44M